About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Massachusetts | 759 Studies

Clinical Trials Lung CancerMassachusetts

Lung Cancer Clinical Trials in Massachusetts

Find 759 clinical trials for lung cancer near Massachusetts. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 759 trials

CompletedA Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)The purpose of this study is to evaluate the efficacy and safety of atezolizumab in combination with tiragolumab compared with durvalumab in participants with locally advanced…NCT04513925·Palo Alto, California and 188 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedPhase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1This is a Phase 1b, open label, multi-center study of CMB305 (sequentially administered LV305 \[a dendritic cell-targeting viral vector expressing the NY-ESO-1 gene\] and G305…NCT02387125·Santa Monica, California and 7 others

Active not recruitingUse of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment DiscontinuationThe goal of this prospective study to investigate the use of circulating tumor DNA (ctDNA) to guide end of therapy decisions in patients with melanoma or non-small-cell lung…NCT06146920·Boston, Massachusetts

RecruitingStereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin ReductionThe goal of this study is to evaluate the feasibility and effectiveness of same-day radiation planning and treatment.NCT07132190·Boston, Massachusetts

Active not recruitingA Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerThis clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC).NCT06012435·Anchorage, Alaska and 330 others

CompletedAZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC PatientsThe purpose of this study is to compare the efficacy of AZD6244 in combination with docetaxel versus docetaxel alone in patients with KRAS mutation positive locally advanced or…NCT00890825·Los Angeles, California and 62 others

CompletedGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemiplimab.NCT05259696·La Jolla, California and 12 others

TerminatedComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryThis phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine versus stereotactic radiosurgery alone in treating patients…NCT04588246·Tucson, Arizona and 80 others

CompletedEffect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line PlatinumThe purpose of this study is to determine if the investigational drug GTx-024 can help patients with non small cell lung cancer increase physical function and maintain or gain…NCT01355497·Birmingham, Alabama and 29 others

RecruitingNeoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung CancerThe study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet…NCT05061550·Little Rock, Arkansas and 96 others

CompletedA Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsThe primary purpose of this study is to evaluate the efficacy of the study drug known as LY2875358, administered alone or in combination with a second drug named Erlotinib, in…NCT01900652·Birmingham, Alabama and 58 others

RecruitingPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesBDTX-4933-101 is a first-in-human, open-label, Phase 1/2 dose escalation, dose optimization and expansion study designed to evaluate the safety and tolerability of S241656 as…NCT05786924·Gilbert, Arizona and 48 others

WithdrawnStudy of Proteins in Tumor Samples From Patients With Non-Small Cell Lung CancerThis research studies protein in tumor samples from patients with non-small cell lung cancer.NCT01415739·Boston, Massachusetts

CompletedA Study of INCAGN01876 in Participants With Advanced or Metastatic Solid TumorsThis was an open-label, non-randomized Phase 1/2 safety study of INCAGN01876 in participants with advanced or metastatic solid tumors that was conducted in 2 parts.NCT02697591·Los Angeles, California and 7 others

RecruitingA Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)NCT07361497·Daphne, Alabama and 258 others

Active not recruitingA Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung CancerThis research study is studying a combination of two targeted therapies as a possible treatment for Non-Small Cell Lung Cancer (NSCLC) with an EGFR mutation.NCT03392246·Boston, Massachusetts and 3 others

CompletedGefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00411047·Boston, Massachusetts

Active not recruitingA Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLCA phase 3 study to demonstrate whether lorlatinib given as monotherapy is superior to crizotinib alone in prolonging the progression-free survival in advanced ALK-positive NSCLC…NCT03052608·Altamonte Springs, Florida and 165 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

CompletedPhase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFRThis research study is a Phase II clinical trial, which tests the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific cancer.NCT01854034·Boston, Massachusetts and 3 others

PreviousPage 10 of 38Next

Other Conditions in Massachusetts

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma